open access

Vol 71, No 4 (2021)
Research paper (original)
Published online: 2021-02-08
Get Citation

The quality of life of patients with head neoplasms and incidence of depression treated with radiotherapy. A preliminary research report

Bogumiła A. Lubińska-Żądło, Anna Pych, Bożena Kowalczyk, Bożena Zawadzka
DOI: 10.5603/NJO.a2021.0015
·
Nowotwory. Journal of Oncology 2021;71(4):212-219.

open access

Vol 71, No 4 (2021)
Original article
Published online: 2021-02-08

Abstract

Introduction. The diagnosis of a primary tumor of the central nervous system is a source of huge fear and anxiety for a patient, because the prognosis is usually unfavorable. Very often, the cancer is accompanied by depression, which reduces the effectiveness of treatment and worsens the patient’s functioning in everyday life.

The aim. The aim of the study is to determine the cause-and-effect relationship between quality of life and incidence of depression, as well as the side effects of treatment in people treated with radiation for head cancer.

Material and methods. The study group consisted of 103 patients during treatment in the Radiotherapy Ward of the Specialist Hospital in Nowy Sącz. The research tools were: the WHO QOL-Bref questionnaire, the Beck Depression Scale and a questionnaire of the author’s own design regarding patients treated with radiation therapy for head cancer.

Results. The general perception of the quality of life in the studied group was 2.88 points, the general perception of the patient’s own health was 1.88 points. The average quality of life was the highest in the environmental field: 62.50 ± 23.21, while the lowest in the physical field: 44.24 ± 28.65.

Conclusions. Both the overall assessment of the quality of life in the assessed areas and the perception of health by patients treated with radiation therapy for head cancer are low.

Abstract

Introduction. The diagnosis of a primary tumor of the central nervous system is a source of huge fear and anxiety for a patient, because the prognosis is usually unfavorable. Very often, the cancer is accompanied by depression, which reduces the effectiveness of treatment and worsens the patient’s functioning in everyday life.

The aim. The aim of the study is to determine the cause-and-effect relationship between quality of life and incidence of depression, as well as the side effects of treatment in people treated with radiation for head cancer.

Material and methods. The study group consisted of 103 patients during treatment in the Radiotherapy Ward of the Specialist Hospital in Nowy Sącz. The research tools were: the WHO QOL-Bref questionnaire, the Beck Depression Scale and a questionnaire of the author’s own design regarding patients treated with radiation therapy for head cancer.

Results. The general perception of the quality of life in the studied group was 2.88 points, the general perception of the patient’s own health was 1.88 points. The average quality of life was the highest in the environmental field: 62.50 ± 23.21, while the lowest in the physical field: 44.24 ± 28.65.

Conclusions. Both the overall assessment of the quality of life in the assessed areas and the perception of health by patients treated with radiation therapy for head cancer are low.

Get Citation

Keywords

head cancer; depression; quality of life

About this article
Title

The quality of life of patients with head neoplasms and incidence of depression treated with radiotherapy. A preliminary research report

Journal

Nowotwory. Journal of Oncology

Issue

Vol 71, No 4 (2021)

Article type

Research paper (original)

Pages

212-219

Published online

2021-02-08

DOI

10.5603/NJO.a2021.0015

Bibliographic record

Nowotwory. Journal of Oncology 2021;71(4):212-219.

Keywords

head cancer
depression
quality of life

Authors

Bogumiła A. Lubińska-Żądło
Anna Pych
Bożena Kowalczyk
Bożena Zawadzka

References (29)
  1. Kozakiewicz B. Nowotwory złośliwe narządu rodnego. Nowa Med. 2003: 122–127.
  2. Walden-Gałuszko K. Psychoonkologia. 1st ed. Polskie Towarzystwo Psychiatryczne, Kraków 2000: 23–43.
  3. Faller H, Olshausen B, Flentje M. [Emotional distress and needs for psychosocial support among breast cancer patients at start of radiotherapy]. Psychother Psychosom Med Psychol. 2003; 53(5): 229–235.
  4. Jacobsen PB, Andrykowski MA, Thors CL. Relationship of catastrophizing to fatigue among women receiving treatment for breast cancer. J Consult Clin Psychol. 2004; 72(2): 355–361.
  5. Jassem J. Paliatywna radioterapia, chemioterapia i leczenie hormonalne. In: Zapaśnik A, Żylicz Z. ed. Leczenie objawowe w chorobie nowotworowej – w okresie daleko zaawansowanym i terminalnym. Akademia Medyczna w Gdańsku, Gdańsk 1993.
  6. Onitilo AA, Nietert PJ, Egede LE. Effect of depression on all-cause mortality in adults with cancer and differential effects by cancer site. Gen Hosp Psychiatry. 2006; 28(5): 396–402.
  7. Jabłoński M, Furgał M, Dudek D, et al. [The position of psychooncology in contemporary psychiatry]. Psychiatr Pol. 2008; 42(5): 749–765.
  8. Pössel P, Adams E, Valentine J. Depression as a risk factor for breast cancer: investigating methodological limitations in the literature. Cancer Causes & Control. 2012; 23(8): 1223–1229.
  9. Polsky D, Doshi JA, Marcus S, et al. Long-term risk for depressive symptoms after a medical diagnosis. Arch Intern Med. 2005; 165(11): 1260–1266.
  10. Wołowicka L, Jaracz K. Wybrane problemy metodologii badań jakości życia związane ze stanem zdrowia. In: Wołowicka L. ed. Jakość życia w naukach medycznych. Wyd. Ucz. AM im. Karola Marcinkowskiego w Poznaniu, Poznań 2001: 233–258.
  11. Zawadzki B, Popiel A, Pragłowska E. Psychometric Properties of the Polish Version of the Aaron T. Beck’s Depression Inventory BDI-II). Psychologia-Etologia- Genetyka. 2009; 19: 71–95.
  12. Oficjalna strona internetowa Szpitala Specjalistycznego im. J. Śniadeckiego w Nowym Sączu. http://www.szpitalnowysacz.pl/zaklad-radioterapii (06.05.2018).
  13. Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory złośliwe w Polsce. Krajowy Rejestr Nowotworów, Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie. http://onkologia.org.pl/raporty (01.03.2019).
  14. Tao Y, Daly-Schveitzer N, Lusinchi A, et al. Advances in radiotherapy of head and neck cancers. Curr Opin Oncol. 2010; 22(3): 194–199.
  15. Szatkowska K, Dreger E, Basińska M. The sense of coherence and the attachment to God among oncological patients and their quality of life. Psychoonkologia. 2016; 20(1): 37–46.
  16. Dziaduszko R, Fijuth J. Epidemiologia i etiologii. In: Dziaduszko R, Fijuth J. ed. Nowotwory ośrodkowego układu nerwowego. 2013: 36–37.
  17. Kowalska M, Humeniuk M, Danso F, et al. [Quality of life of occupationally active people, aged 45-60, living in the Polish industrial region (Silesian agglomeration)]. Med Pr. 2011; 62(5): 455–463.
  18. Kowalska M, Szemik S. Quality of life in adult inhabitants of Silesian voivodeship, aged 25-44 years – preliminary results. Probl Hig Epidemiol. 2016; 97(2): 172–176.
  19. Kozaka J, Senkus-Konefka E, Kowalczyk A, et al. 310. Wpływ amifostyny na jakość życia chorych na nowotwory głowy i szyi otrzymujących radioterapię. Reports of Practical Oncology & Radiotherapy. 2003; 8: S345–S346.
  20. Mitchell AJ, Lord K, Symonds P. Which symptoms are indicative of DSMIV depression in cancer settings? An analysis of the diagnostic significance of somatic and non-somatic symptoms. J Affect Disord. 2012; 138(1-2): 137–148.
  21. Mitchell A, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. The Lancet Oncology. 2011; 12(2): 160–174.
  22. Kapela I, Bąk E, Krzemińska S, et al. Evaluation of the level of acceptance of the disease and of satisfaction with life in patients with colorectal cancer treated with chemotherapy. Nursing and Public Health. 2017; 7(1): 53–61.
  23. Nowak A, Babiarczyk B, Skoczylas K. The effect of pain control and management strategies on psychological adaptation to cancer. Journal of Public Health, Nursing and Medical Rescue. 2018; 3: 6–12.
  24. Kurpas D, Bąk E, Seń M, et al. Quality of life in patients of the interventional cardiology unit. Family Medicine and Primary Care Review. 2014; 16(2): 120–123.
  25. Smoleń E, Słysz M, Jarema M, et al. Czynniki warunkujące styl przystosowania do choroby u pacjentów leczonych onkologicznie. Journal of Education, Health and Sport. 2017; 7(08): 1715–1732.
  26. Szczepańska-Gieracha J, Malicka I, Rymaszewska J, et al. Psychological adjustment of women after oncological surgery and at the end of treatment. Współczesna Onkologia. 2010; 6: 403–410.
  27. Smoleń E, Hombek K, Jarema M, et al. Factors determining the acceptance of the disease in patients treated oncologically. Medycyna Ogólna i Nauki o Zdrowiu. 2018; 24(1): 37–43.
  28. Ślusarska B, Nowicki GJ, Serwata M. Level of disease acceptance and quality of life in people with lymphoma. Palliative Medicine. 2016; 8(2): 88–95.
  29. Zapała J, Zawadzka B, Pyk M. Cancer and diabetes – similarities and differences in prevention. Probl Hig Epidemiol. 2018; 99(3): 205–210.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media sp. z o.o. VM Group sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl